Accelerate Diagnostics, Inc. (AXDX) Financial Statements
$0.03NASDAQ: AXDXMarket Cap $859918
Accelerate Diagnostics, Inc. most recently reported annual revenue of $12.0M, net profit of $-50.0M, revenue has compounded at 5.9% a year over the last five years. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.